Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

2,532 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Mycophenolate mofetil use after unrelated hematopoietic stem cell transplantation for prophylaxis and treatment of graft-vs.-host disease in adult patients in Japan.
Iida M, Fukuda T, Uchida N, Murata M, Aotsuka N, Minagawa K, Oohashi K, Fukushima K, Kondo T, Eto T, Miyamoto T, Morishima Y, Nagamura T, Atsuta Y, Suzuki R. Iida M, et al. Among authors: fukushima k. Clin Transplant. 2014 Sep;28(9):980-9. doi: 10.1111/ctr.12405. Epub 2014 Jul 17. Clin Transplant. 2014. PMID: 24943923 Free article.
Therapy-related acute myeloid leukemia and myelodysplastic syndrome after hematopoietic cell transplantation for lymphoma.
Yamasaki S, Suzuki R, Hatano K, Fukushima K, Iida H, Morishima S, Suehiro Y, Fukuda T, Uchida N, Uchiyama H, Ikeda H, Yokota A, Tsukasaki K, Yamaguchi H, Kuroda J, Nakamae H, Adachi Y, Matsuoka KI, Nakamura Y, Atsuta Y, Suzumiya J. Yamasaki S, et al. Among authors: fukushima k. Bone Marrow Transplant. 2017 Jul;52(7):969-976. doi: 10.1038/bmt.2017.52. Epub 2017 Apr 3. Bone Marrow Transplant. 2017. PMID: 28368379 Clinical Trial.
Addition of melphalan to fludarabine/busulfan (FLU/BU4/MEL) provides survival benefit for patients with myeloid malignancy following allogeneic bone-marrow transplantation/peripheral blood stem-cell transplantation.
Ueda T, Maeda T, Kusakabe S, Fujita J, Fukushima K, Yokota T, Shibayama H, Tomiyama Y, Kanakura Y. Ueda T, et al. Among authors: fukushima k. Int J Hematol. 2019 Feb;109(2):197-205. doi: 10.1007/s12185-018-2562-8. Epub 2018 Nov 17. Int J Hematol. 2019. PMID: 30448938
Influence of HLA 1-3-locus mismatch and antithymocyte globulin administration in unrelated bone marrow transplantation.
Kawamura K, Kanda J, Ohashi K, Fukuda T, Iwato K, Eto T, Fujiwara SI, Mori T, Fukushima K, Ozawa Y, Uchida N, Ashida T, Ichinohe T, Atsuta Y, Kanda Y. Kawamura K, et al. Among authors: fukushima k. Ann Hematol. 2020 May;99(5):1099-1110. doi: 10.1007/s00277-020-03995-7. Epub 2020 Mar 23. Ann Hematol. 2020. PMID: 32206853 Clinical Trial.
Outcome of Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Myelodysplastic/Myeloproliferative Neoplasms-Unclassifiable: A Retrospective Nationwide Study of the Japan Society for Hematopoietic Cell Transplantation.
Kurosawa S, Shimomura Y, Tachibana T, Ishiyama K, Ota S, Kobayashi T, Uchida N, Fukushima K, Ashida T, Matsuoka KI, Kanda J, Ichinohe T, Atsuta Y, Murata M, Aoki J. Kurosawa S, et al. Among authors: fukushima k. Biol Blood Marrow Transplant. 2020 Sep;26(9):1607-1611. doi: 10.1016/j.bbmt.2020.05.013. Epub 2020 May 23. Biol Blood Marrow Transplant. 2020. PMID: 32454216 Free article.
Negative Impact of Cytomegalovirus Reactivation on Survival in Adult Patients with Aplastic Anemia after an Allogeneic Hematopoietic Stem Cell Transplantation: A Report from Transplantation-Related Complication and Adult Aplastic Anemia Working Groups of the Japan Society for Hematopoietic Cell Transplantation.
Takenaka K, Onishi Y, Mori T, Hirakawa T, Tada Y, Uchida N, Kobayashi T, Kanda Y, Ozawa Y, Ota S, Iida H, Fukushima K, Kimua T, Fukuda T, Atsuta Y, Matsuto K, Yamazaki H, Nakasone H. Takenaka K, et al. Among authors: fukushima k. Transplant Cell Ther. 2021 Jan;27(1):82.e1-82.e8. doi: 10.1016/j.bbmt.2020.10.001. Epub 2020 Oct 9. Transplant Cell Ther. 2021. PMID: 33039517 Free article.
Low diversity of gut microbiota in the early phase of post-bone marrow transplantation increases the risk of chronic graft-versus-host disease.
Konishi T, Kusakabe S, Hino A, Inamoto K, Yoshifuji K, Kiridoshi Y, Takeshita K, Sasajima S, Toya T, Igarashi A, Najima Y, Kobayashi T, Doki N, Motooka D, Nakamura S, Suyama M, Suda W, Shiota A, Atarashi K, Hattori M, Honda K, Yokota T, Ohashi K, Shibayama H, Fukushima K, Kakihana K. Konishi T, et al. Among authors: fukushima k. Bone Marrow Transplant. 2021 Jul;56(7):1728-1731. doi: 10.1038/s41409-021-01249-2. Epub 2021 Mar 8. Bone Marrow Transplant. 2021. PMID: 33686248 No abstract available.
High numbers of programmed cell death-1-positive tumor infiltrating lymphocytes correlate with early onset of post-transplant lymphoproliferative disorder.
Saito H, Miyoshi H, Shibayama H, Toda J, Kusakabe S, Ichii M, Fujita J, Fukushima K, Maeda T, Mizuki M, Oritani K, Seto M, Yokota T, Kanakura Y, Hosen N, Ohshima K. Saito H, et al. Among authors: fukushima k. Int J Hematol. 2021 Jul;114(1):53-64. doi: 10.1007/s12185-021-03129-3. Epub 2021 Mar 25. Int J Hematol. 2021. PMID: 33765256
Allogeneic hematopoietic stem cell transplantation for myelodysplastic syndrome in adolescent and young adult patients.
Shimomura Y, Hara M, Konuma T, Itonaga H, Doki N, Ozawa Y, Eto T, Uchida N, Aoki J, Kato J, Onishi Y, Takahashi S, Fukushima K, Nakamae H, Kawakita T, Tanaka J, Fukuda T, Atsuta Y, Ishikawa T, Ishiyama K. Shimomura Y, et al. Among authors: fukushima k. Bone Marrow Transplant. 2021 Oct;56(10):2510-2517. doi: 10.1038/s41409-021-01324-8. Epub 2021 May 15. Bone Marrow Transplant. 2021. PMID: 33993196
2,532 results